This makes sense: biologics are notoriously tricky to manufacture, and both their safety and efficacy depends not only on the specific protein sequence of the molecule, but on the highly specific culture conditions used to manufacture it.

FORBES: Strategy: Why Big Pharmas Do What They Do -- And How Silicon Valley Might Help Them Think Differently